Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-19T07:11:05.724Z Has data issue: false hasContentIssue false
  • English
  • Français

Drug handling by the aging liver: past work and future directions

Published online by Cambridge University Press:  17 November 2008

Ken Woodhouse
Ken Woodhouse*
Affiliation:
University of Wales College of Medicine, Penarth, UK
*
Department of Geriatric Medicine, University of Wales College of Medicine, Academic Centre, Llandough Hospital, Penarth CF64 2XX, UK.
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Biological gerontology
Information
Reviews in Clinical Gerontology , Volume 6 , Issue 3 , August 1996 , pp. 215 - 223
Copyright
Copyright © Cambridge University Press 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Office of Health Economics (OHE). OHW Briefing No. 13: Effect of prescription charges. London: OHE, 1980.Google Scholar
2Skoll, SL, August, RJ, Johnson, GE. Drug prescribing for the elderly in Saskatchewan during 1976. Can Med Assoc J 1979; 121: 1074.Google ScholarPubMed
3Guttman, D. Patterns of legal drug use by older Americans. Addict Dis Int J 1978; 3: 337.Google Scholar
4Schmucker, DL. Age-related changes in drug disposition. Pharmacol Rev 1979; 30: 445–56.Google Scholar
5Greenblatt, DJ, Sellars, EM, Shader, RI. Drug disposition in old age. N Engl J Med 1982; 306: 1081–88.Google ScholarPubMed
6Schmucker, DL. Aging and drug disposition: an update. Pharmacol Rev 1985; 37: 133–48.Google Scholar
7Woodhouse, KW, James, OFW. Hepatic drug metabolism and ageing. Br Med Bull 1990; 46: 22–35.CrossRefGoogle ScholarPubMed
8O'Mahony, MS, Woodhouse, KW. Age, environmental factors and drug metabolism. Pharmacol Ther 1994; 61: 279–87.CrossRefGoogle ScholarPubMed
9Williams, RT. Comparative patterns of drug metabolism. Fed Proc 1967; 26: 1029–39.Google ScholarPubMed
10Vessell, ES. The antipyrine test in clinical pharmacology: conceptions of misconceptions. Clin Pharmacol Ther 1979; 26: 275–86.CrossRefGoogle Scholar
11Stevenson, IH. Factors influencing antipyrine elimination. Br J Clin Pharmacol 1977; 4: 261–65.CrossRefGoogle ScholarPubMed
12O'Malley, K, Crooks, J, Duke, E et al. Effect of age and sex on human drug metabolism. BMJ 1971; 3: 607–609.CrossRefGoogle ScholarPubMed
13Greenblatt, DJ, Divoll, MK, Harmatz, JS et al. Antipyrine absorption and disposition in the elderly. Pharmacology 1988; 36: 125–33.CrossRefGoogle ScholarPubMed
14Wood, AJJ, Vestal, RE, Wilkinson, GR et al. Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination. Clin Pharmacol Ther 1979; 26: 16–20.CrossRefGoogle ScholarPubMed
15Hartleb, M. Drugs and the liver. II. The role of the antipyrine test in drug metabolism studies. Biopharm Drug Dispos 1991; 12: 559–70.CrossRefGoogle ScholarPubMed
16Posner, J, Danhof, M, Teunissen, MWE, Breimer, DD, Whitieman, PP. The disposition of antipyrine and its metabolites in young and elderly healthy volunteers. Br J Clin Pharmacol 1987; 24: 51–5.CrossRefGoogle Scholar
17Wynne, HA, Cope, LH, James, OFW, Rawlins, MD, Woodhouse, KW. The effect of age and frailty upon acetanilide clearance. Age Ageing 1989; 18: 415–18.CrossRefGoogle ScholarPubMed
18Greenblatt, DJ, Sellers, EM, Shade, RI. Drug disposition in old age. N Engl J Med 1982; 306: 1081–88.Google ScholarPubMed
19Nation, RL, Learoyd, B, Barber, J, Triggs, EJ. The pharmacokinetics of chlormethiazole following intravenous administration in the aged. Eur J Clin Pharmacol 1976; 10: 407–15.CrossRefGoogle ScholarPubMed
20Bach, B, Hansen, JM, Kampmann, JP, Rasmussen, SN, Skovsted, L. Disposition of antipyrine and phenytoin correlated with age and liver volume in man. Clin Pharmacokinet 1981; 6: 389–96.CrossRefGoogle ScholarPubMed
21Robertson, DRC, Waller, DG, Renwick, AG, George, CF. Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine. Br J Clin Pharmacol 1988; 25: 297–305.CrossRefGoogle ScholarPubMed
22Jackson, SHD, Johnston, A, Wollard, R, Turner, P. The relationship between theophylline clearance and age in adult life. Eur J Pharmacol 1989; 36: 29–34.Google ScholarPubMed
23Sorstein, L, Larsen, A, Midtbo, K, Saevareid, L. Pharmacokinetics of calcium channel blockers in patients with renal insufficiency and in geriatric patients. Acta Med Scand 1984; 681 (suppl 2): 25–30.Google Scholar
24Hunt, CM, Westerkam, SR, Stave, M. Effect of age and gender on the activity of human hepatic Cyp3A. Biochem Pharmacol 1992; 44: 275–83.CrossRefGoogle ScholarPubMed
25Hunt, CM, Westerkam, WR, Stave, M, Wilson, J. Human hepatic cytochrome P4503A (CYP3A) activity in the elderly. Mech Ageing Dev 1992; 64: 189–99.CrossRefGoogle ScholarPubMed
26Gonzalez, FJ, Skoda, RC, Kimura, S et al. Characterization of the common defect in humans deficient in debrisoquine metabolism. Nature 1988; 331: 442–46.CrossRefGoogle ScholarPubMed
27Lennard, MS, Tucker, GT, Silas, JH, Woods, HEDebrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenolol. Xenobiotica 1986; 16: 435–47.CrossRefGoogle Scholar
28Kroemer, HK, Mikus, G, Kronbach, J, Meyer, UA, Eichelbaum, M. In vitro characterization of the human cytochrome P450 involved in the polymorphic oxidation of propafenone. Clin Pharmacol Ther 1989; 45: 28–33.CrossRefGoogle ScholarPubMed
29Haefeli, WE, Bargetzi, MJ, Follath, F, Meyer, UA. Potent inhibition of cytochrome P450IID6 (debrisoquine 4-hydroxylase) by flecainide in vitro and in vivo. J Cardiovasc Pharmacol 1990; 15: 776–79.CrossRefGoogle ScholarPubMed
30Vestal, RE, Norris, AH, Tobin, JD, Cohen, BH, Shock, NW, Andres, R. Antipyrine metabolism in man: influence of age, alcohol, caffeine and smoking. Clin Pharmacol Ther 1975; 18: 425–32.CrossRefGoogle ScholarPubMed
31Wood, AJ, Vestal, RE, Wilkinson, GR, Branch, RA, Shand, DC. Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination. Clin Pharmacol Ther 1979; 26: 16–20.CrossRefGoogle ScholarPubMed
32Divoll, M, Ameer, B, Abernathy, DJ, Greenblatt, DJ. Age does not alter acetaminophen absorption. J Am Ceriatr Soc 1982; 30: 240–44.Google Scholar
33Murray, TG, Chiang, ST, Koepke, HH, Walker, BR. Renal disease, age and oxazepam kinetics. Clin Pharmacol Ther 1981; 30: 805–809.CrossRefGoogle ScholarPubMed
34Posner, J, Holdich, T, Crome, P. Comparison of lamotrigine pharmacokinetics in young and elderly healthy volunteers. J Pharm Med 1991; 1: 121–21.Google Scholar
35Greenblatt, DJ, Allen, MD, Locniskar, A, Harmatz, JS, Shader, RI. Larazepam kinetics in the elderly. Clin Pharmacol Ther 1979; 26: 103–13.CrossRefGoogle Scholar
36Baillie, SP, Bateman, DN, Coates, PE, Woodhouse, KW. Age and the pharmacokinetics of morphine. Age Ageing 1989; 18: 258–62.CrossRefGoogle ScholarPubMed
37Wynne, HA, Cope, LH, Herd, B, Rawlins, MD, James, OFW, Woodhouse, KW. The association of age and frailty with paracetamol conjugation in man. Age Ageing 1990; 19: 419–24.CrossRefGoogle ScholarPubMed
38Boyd, E. Normal variability of weight of the adult human liver and spleen. Arch Pathol 1933; 16: 350–72.Google Scholar
39Woodhouse, KW, Wynne, H. Age-related changes in hepatic function: implications for drug therapy. Drugs Aging 1992; 2: 243–55.CrossRefGoogle ScholarPubMed
40Swift, CG, Homeida, M, Halliwell, M, Roberts, CJ. Antipyrine disposition and liver size in the elderly. Eur J Clin Pharmacol 1978; 14: 149–52.CrossRefGoogle ScholarPubMed
41Wynne, H, Cope, L, Mutch, E, Rawlins, MD, Woodhouse, KW, James, OFW. The effect of age upon liver size and liver blood flow in man. Hepatology 1989; 9: 297–301.CrossRefGoogle Scholar
42Marchesini, G, Bianchi, GP, Fabbri, A et al. Synthesis of urea after a protein-rich meal in normal man in relation to ageing. Age Ageing 1990; 19: 4–10.CrossRefGoogle ScholarPubMed
43Wynne, H, Goudouvenous, J, Adams, P, Rawlins, MD, James, OFW, Woodhouse, KW. Hepatic extraction of drugs: the effect of age using indocyanine green as a model substrate. Br J Clin Pharmacol 1990; 30: 634–37.CrossRefGoogle Scholar
44Kato, R, Vassenelli, P, Frontino, G. Variation in the activity of liver microsomal drug metabolising enzymes in rats in relation to age. Biochem Pharmacol 1964; 12: 1037–51.CrossRefGoogle Scholar
45Vestal, RE. Aging and determinants of hepatic drug clearance. Hepatology 1989; 9: 331–34.CrossRefGoogle ScholarPubMed
46Maloney, AG, Schmucker, DL, Vessey, DS et al. The effects of ageing on the hepatic microsomal mixed-function oxidase system of male and female monkeys. Hepatology 1986; 6: 282–87.CrossRefGoogle ScholarPubMed
47Sutter, MA, Wood, WG, Williamson, LS et al. Comparison of the hepatic mixed function oxidase system of young adults, and old non-human primates (Macco nemestrina). Biochem Pharmacol 1985; 34: 2983–87.CrossRefGoogle Scholar
48Woodhouse, KW, Mutch, E, Williams, FM, Rawlins, MD, James, OFW. The effect of age on pathways of drug metabolism in human liver. Age Ageing 1984; 113: 328–34.CrossRefGoogle Scholar
49Schmucker, DL, Woodhouse, KW, Wang, RK et al. Effect of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin Pharm Ther 1990; 48: 365–74.CrossRefGoogle ScholarPubMed
50Wynne, H, Mutch, E, James, OFW, Wright, IP, Rawlins, MD, Woodhouse, KW. The effect of age upon the affinity of microsomal monooxygenase enzymes for substrate in human liver. Age Ageing 1988; 17: 401–405.CrossRefGoogle ScholarPubMed
51Wynne, H, Mutch, E, James, OFW, Fawlins, MD, Woodhouse, KW. Effect of age on monooxygenase enzyme kinetics in rat liver microsomes. Age Ageing 1987; 16: 153–58.CrossRefGoogle ScholarPubMed
52Vestal, H, McGuire, E, Tobin, J, Andres, R, Norris, A, Mezey, E. Aging and ethanol metabolism. Clin Pharmacol Ther 1977; 21: 343–54.CrossRefGoogle ScholarPubMed
53Williams, FM, Wynne, H, Woodhouse, KW, Rawlins, MD. Plasma aspirin esterase: the influence of old age and frailty. Age Ageing 1989; 18: 39–42.CrossRefGoogle ScholarPubMed
54Yelland, C, Nicholson, E, Wynne, H, Woodhouse, KW. The effect of age upon aspirin esterase activity in human liver. Age Ageing 1991; 20: 16–18.CrossRefGoogle Scholar
55Ali, M, Nicholls, PJ, Yoosuf, A. The influence of old age and of renal failure on hepatic glucuronidation in the rat. Proceedings of the British Pharmaceutical Society, 04 1979: 498–99.Google ScholarPubMed
56Borghoff, SJ, Birnhaum, LS. Age-related changes in glucuronidation and deglucuronidation in liver, small intestine, lung and kidney of male Fischer rats. Drug Metab Dispos 1985; 13: 62–67.Google ScholarPubMed
57Woodhouse, KW, Herd, B. The effect of age and gender on glucuronidation and sulphation in rat liver: a study using paracetamol as a model substrate. Arch Cerontol Geriatr 1993; 16: 111–15.CrossRefGoogle ScholarPubMed
58Herd, B, Wynne, H, Wright, P, James, OFW, Woodhouse, KW. The effect of age on glucuronidation and sulphation of paracetamol by human liver fractions. Br J Clin Pharmacol 1991; 32: 768–70.CrossRefGoogle ScholarPubMed
59Spearman, ME, Leibman, KC. Effects of aging on hepatic and pulmonary glutathione-S-transferase activities in male and female Fischer 344 rats. Biochem Pharmacol 1984; 33: 1309–13.CrossRefGoogle ScholarPubMed
60Sweeny, DJ, Weiner, M. Metabolism of acetaminophen in hepatocytes isolated from mice and rats of various ages. Drug Metab 1985; 13: 377–79.Google ScholarPubMed
61Kato, R, Takanaka, A. Effects of phenobarbital on electron transport system. Oxidation and reduction of drugs in liver microsomes of rats of different ages. J Biochem (Tokyo) 1968; 63: 406–408.Google Scholar
62Schmucker, DL, Wang, RK. Effects of aging and phenobarbital on the rat liver microsomal drug metabolising system. Mech Ageing Dev 1981; 15: 189–202.CrossRefGoogle Scholar
63Horback, GJ, van Asten, JG, van Bezooijen, CFA. The influence of ageing on the induction of the mRNAs of rat liver cytochromes P450IIB1 and P450IIB2. Biochem Pharmacol 1990; 40: 529–33.CrossRefGoogle Scholar
64Beckett, AH, Triggs, EJ. Enzyme induction in man caused by smoking. Nature 1967; 216: 587–88.CrossRefGoogle ScholarPubMed
65Jenne, J, Nagasawa, H, McHugh, R, MacDonald, F, Wyse, E. Decreased theophylline half-life in cigarette smokers. Life Sci 1975; 17: 195–98.CrossRefGoogle ScholarPubMed
66Vestal, RE, Norris, AH, Tobin, JD, Cohen, BH, Shock, NW, Andres, R. Antipyrine metabolism in man: influence of age, alcohol, caffeine and smoking. Clin Pharmacol Ther 1975; 18: 425–32.CrossRefGoogle ScholarPubMed
67Vestal, RE, Wood, AJJ, Branch, RA, Shand, DG, Wilkinson, GR. Effects of age and cigarette smoking on propranolol disposition. Clin Pharmacol Ther 1979; 26: 8–15.CrossRefGoogle ScholarPubMed
68Mucklow, JC, Fraser, HS. The effects of age and smoking upon antipyrine metabolism. J Clin Pharmacol 1980; 9: 612–14.Google ScholarPubMed
69Crowley, JJ, Cusack, BJ, Jue, SG, Koup, JR, Park, BK, Vestal, RE. Ageing and drug interactions II. Effect of phenytoin and smoking on the oxidation of theophylline and cortisol in healthy man. J Pharmacol Exp Ther 1988; 245: 513–23.Google Scholar
70Bonde, J, Pedersen, LE, Bodtker, S, Angelo, HR, Svendsen, TL, Kampmann, JP. the influence of age and smoking on the elimination of disopyramide. Br J Clin Pharmacol 1985; 20: 453–58.CrossRefGoogle ScholarPubMed
71Salem, SAM, Rajjayabun, P, Shepherd, AMM, Stevenson, IH. Reduced induction of drug metabolism in the elderly. Age Ageing 1978; 7: 68–73.CrossRefGoogle ScholarPubMed
72Twum-Barima, Y, Finnigan, T, Habbash, AI, Cape, RD, Carruthers, SF. Impaired enzyme induction of rifampicin in the elderly. Br J Clin Pharmacol 1984; 17: 595–97.CrossRefGoogle ScholarPubMed
73Pearson, MW, Roberts, CJC. Drug induction of hepatic enzymes in the elderly. Age Ageing 1984; 13: 313–164.CrossRefGoogle ScholarPubMed
74Brodie, MJ, Boobis, AR, Bulpirt, CJ, Davies, DS. Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro. Eur J Clin Pharmacol 1981; 20: 39–46.CrossRefGoogle ScholarPubMed
75Boobis, AR, Murray, S, Seddon, CE, Davies, DS. In vitro studies of induction and inhibition of drug oxidation in man. Pharmacol Ther 1987; 33: 101–108.CrossRefGoogle ScholarPubMed
76George, G, Wynne, HA, Woodhouse, KW. The association of age with the induction of drug metabolising enzymes in human monocytes. Age Ageing 1990; 19: 364–67.CrossRefGoogle Scholar
77George, G, Wynne, H, Woodhouse, K. Age and the rate of induction in aryl hydrocarbon hydroxylase in isolated peripheral blood monocytes. Age Ageing 1991; 20: 421–23.CrossRefGoogle ScholarPubMed
78George, G, Woodhouse, K. Dose-dependent induction of the microsomal monooxygenase aryl hydrocarbon hydroxylase in isolated peripheral blood monocytes: the influence of age. Pharmacol Toxicol 1992; 71: 221–23.CrossRefGoogle Scholar
79George, G, O'Mahony, S, Woodhouse, K. Age, smoking and the activity of the monooxygenase aryl hydrocarbon hydroxylase in isolated human peripheral blood monocytes. Age Ageing 1994; 23: 421–24.CrossRefGoogle ScholarPubMed
80Woodhouse, KW, Wynne, H, Baillie, S, James, OFW, Rawlins, MD. Who are the frail elderly? Q J Med 1988; 68: 505–506.Google ScholarPubMed
81Anderson, KE. Nutritional effects on hepatic drug metabolism in the elderly. In: Prinsley, DM, Sandstead, HH eds. Nutrition and aging. New York: Alan R Liss Inc., 1990: 263–77.Google Scholar
82Anderson, KE, Conney, AH, Kappas, A. Nutrition and oxidative drug metabolism in man: relative influence of dietary lipids, carbohydrate and protein. Clin Pharmacol Ther 1979; 26: 493–501.CrossRefGoogle ScholarPubMed
83Holloway, DE, Peterson, FJ. Ascorbic acid in drug metabolism. In: Roe, DA, Campbell, JC eds. Drug and nutrients: the interactive effects. New York: Marcel Dekker Inc., 1984: 225–95.Google Scholar
84Pantuck, EJ, Pantuck, CB, Garland, WA et al. Stimulatory effect of Brussels sprouts and cabbage on human drug metabolism. Clin Pharmacol Ther 1979; 25: 88–95.CrossRefGoogle ScholarPubMed
85Bienia, R, Ratcliff, S, Barbour, GL, Kummer, M. Malnutrition in the hospitalised geriatric patient. J Am Ceriatr Soc 1982; 30: 433–36.Google ScholarPubMed
86Bistrian, BR, Blackburn, GL, Vitale, J, Cochran, D, Naylor, J. Prevalence of malnutrition in general medical patients. J Am Med Assoc 1976; 235: 1567–70.CrossRefGoogle ScholarPubMed
87Summerbell, J, Williams, FM, Hankey, CR, Wynne, HA. The effect of age and frailty upon paraox-onase and aryl esterase activities and their response to a period of nutritional supplementation. In: Woodhouse, KW, O'Mahony, MS eds. Drug metabolism, liver injury and ageing. Leiden: Eurage, 1991: 23–32.Google Scholar
88O'Mahoney, MS, George, G, Westlake, H, Woodhouse, K. Plasma aspirin esterase activity in elderly patients undergoing elective hip replacement and with fractured neck of femur. Age Ageing 1994; 23: 338–41.CrossRefGoogle ScholarPubMed